Paper24672522
Improving the outcome of leukemia by natural killer cell-based immunotherapeutic strategies.
Chouaib S and 6 others. Front Immunol, 2014. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Improving the outcome of leukemia by natural killer cell-based immunotherapeutic strategies. Papers, record 24672522. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24672522
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Improving the outcome of leukemia by natural killer cell-based immunotherapeutic strategies.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References118
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11160200 | Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells. | J Immunol | 2001 | https://conductscience.org/library/papers/11160200 | PubMed |
| 2 | 14985163 | Ex vivo expansion of natural killer cells for clinical applications. | Cytotherapy | 2004 | https://conductscience.org/library/papers/14985163 | PubMed |
| 3 | 19383914 | Expansion of highly cytotoxic human natural killer cells for cancer cell therapy. | Cancer Res | 2009 | https://conductscience.org/library/papers/19383914 | PubMed |
| 4 | 22234167 | The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation. | Hum Immunol | 2012 | https://conductscience.org/library/papers/22234167 | PubMed |
| 5 | 9430220 | Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. | Immunity | 1997 | https://conductscience.org/library/papers/9430220 | PubMed |
| 6 | 11861603 | KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. | Annu Rev Immunol | 2002 | https://conductscience.org/library/papers/11861603 | PubMed |
| 7 | 18055229 | Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. | Immunity | 2007 | https://conductscience.org/library/papers/18055229 | PubMed |
| 8 | 11600215 | A new method for in vitro expansion of cytotoxic human CD3-CD56+ natural killer cells. | Hum Immunol | 2001 | https://conductscience.org/library/papers/11600215 | PubMed |
| 9 | 9126959 | A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. | J Immunol | 1997 | https://conductscience.org/library/papers/9126959 | PubMed |
| 10 | 21045194 | NK-cell education is shaped by donor HLA genotype after unrelated allogeneic hematopoietic stem cell transplantation. | Blood | 2011 | https://conductscience.org/library/papers/21045194 | PubMed |
| 11 | 21698239 | Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process. | PLoS One | 2011 | https://conductscience.org/library/papers/21698239 | PubMed |
| 12 | 1384796 | The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture. | Blood | 1992 | https://conductscience.org/library/papers/1384796 | PubMed |
| 13 | 11859120 | Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. | J Immunol | 2002 | https://conductscience.org/library/papers/11859120 | PubMed |
| 14 | 16892071 | Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders. | Bone Marrow Transplant | 2006 | https://conductscience.org/library/papers/16892071 | PubMed |
| 15 | 20670353 | Ex vivo expansion of natural killer cells with high cytotoxicity by K562 cells modified to co-express major histocompatibility complex class I chain-related protein A, 4-1BB ligand, and interleukin-15. | Tissue Antigens | 2010 | https://conductscience.org/library/papers/20670353 | PubMed |
| 16 | 15654351 | Use of natural killer cells in hematopoetic stem cell transplantation. | Bone Marrow Transplant | 2005 | https://conductscience.org/library/papers/15654351 | PubMed |
| 17 | 7650366 | Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. | J Immunol | 1995 | https://conductscience.org/library/papers/7650366 | PubMed |
| 18 | 20093094 | Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells. | Clin Immunol | 2010 | https://conductscience.org/library/papers/20093094 | PubMed |
| 19 | 15536148 | Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias. | Blood | 2005 | https://conductscience.org/library/papers/15536148 | PubMed |
| 20 | 24094496 | Treatment of patients with advanced cancer with the natural killer cell line NK-92. | Cytotherapy | 2013 | https://conductscience.org/library/papers/24094496 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37751103 | NK Cell Therapeutics for Hematologic Malignancies: from Potential to Fruition. | Curr Hematol Malig Rep | 2023 | https://conductscience.org/library/papers/37751103 | PubMed |
| 36381305 | Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β. | Mol Ther Methods Clin Dev | 2022 | https://conductscience.org/library/papers/36381305 | PubMed |
| 35919498 | Establishment of an efficient ex vivo expansion strategy for human natural killer cells stimulated by defined cytokine cocktail and antibodies against natural killer cell activating receptors. | Regen Ther | 2022 | https://conductscience.org/library/papers/35919498 | PubMed |
| 35589475 | Comparable transforming growth factor beta-mediated immune suppression in ex vivo-expanded natural killer cells from cord blood and peripheral blood: implications for adoptive immunotherapy. | Cytotherapy | 2022 | https://conductscience.org/library/papers/35589475 | PubMed |
| 35401529 | Innovative Strategies to Improve the Clinical Application of NK Cell-Based Immunotherapy. | Front Immunol | 2022 | https://conductscience.org/library/papers/35401529 | PubMed |
| 35349491 | Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse. | J Clin Invest | 2022 | https://conductscience.org/library/papers/35349491 | PubMed |
| 34215336 | CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies. | Stem Cell Res Ther | 2021 | https://conductscience.org/library/papers/34215336 | PubMed |
| 33120910 | Natural Killer Cells in Immunotherapy: Are We Nearly There? | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33120910 | PubMed |
| 29755462 | Comparison of Phenotypic and Functional Characteristics Between Canine Non-B, Non-T Natural Killer Lymphocytes and CD3+CD5dimCD21- Cytotoxic Large Granular Lymphocytes. | Front Immunol | 2018 | https://conductscience.org/library/papers/29755462 | PubMed |
| 29364266 | Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells. | J Vis Exp | 2018 | https://conductscience.org/library/papers/29364266 | PubMed |
| 29123958 | Expression of CD94 by ex vivo-differentiated NK cells correlates with the in vitro and in vivo acquisition of cytotoxic features. | Oncoimmunology | 2017 | https://conductscience.org/library/papers/29123958 | PubMed |
| 28791027 | CD56 in the Immune System: More Than a Marker for Cytotoxicity? | Front Immunol | 2017 | https://conductscience.org/library/papers/28791027 | PubMed |
| 28668320 | Engineering Natural Killer Cells for Cancer Immunotherapy. | Mol Ther | 2017 | https://conductscience.org/library/papers/28668320 | PubMed |
| 27141397 | Advances in clinical NK cell studies: Donor selection, manufacturing and quality control. | Oncoimmunology | 2016 | https://conductscience.org/library/papers/27141397 | PubMed |
| 26810567 | Selection and expansion of natural killer cells for NK cell-based immunotherapy. | Cancer Immunol Immunother | 2016 | https://conductscience.org/library/papers/26810567 | PubMed |
| 26770944 | A multifaceted approach targeting NK cells for better treatment of cancer: focus on hematological malignancies. | Blood Res | 2015 | https://conductscience.org/library/papers/26770944 | PubMed |
| 26692928 | Matrine increases NKG2D ligand ULBP2 in K562 cells via inhibiting JAK/STAT3 pathway: a potential mechanism underlying the immunotherapy of matrine in leukemia. | Am J Transl Res | 2015 | https://conductscience.org/library/papers/26692928 | PubMed |
| 26635792 | The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer. | Front Immunol | 2015 | https://conductscience.org/library/papers/26635792 | PubMed |
| 26457276 | Cellular immunotherapy as a beacon of hope for hematological malignancies. | Blood Res | 2015 | https://conductscience.org/library/papers/26457276 | PubMed |
| 26029215 | Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies. | Front Immunol | 2015 | https://conductscience.org/library/papers/26029215 | PubMed |
Genes40
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24672522
GET https://conductscience.org/api/papers/v1/24672522/references?page=2